CVRX vs. TELA, NPCE, SMTI, XAIR, PAVM, PLSE, OFIX, SIBN, BVS, and IRMD
Should you be buying CVRx stock or one of its competitors? The main competitors of CVRx include TELA Bio (TELA), NeuroPace (NPCE), Sanara MedTech (SMTI), Beyond Air (XAIR), PAVmed (PAVM), Pulse Biosciences (PLSE), Orthofix Medical (OFIX), SI-BONE (SIBN), Bioventus (BVS), and Iradimed (IRMD). These companies are all part of the "medical" sector.
TELA Bio (NASDAQ:TELA) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, valuation, earnings, institutional ownership, risk, analyst recommendations, profitability and community ranking.
94.4% of TELA Bio shares are owned by institutional investors. Comparatively, 75.3% of CVRx shares are owned by institutional investors. 6.0% of TELA Bio shares are owned by insiders. Comparatively, 18.9% of CVRx shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
In the previous week, CVRx had 3 more articles in the media than TELA Bio. MarketBeat recorded 4 mentions for CVRx and 1 mentions for TELA Bio. CVRx's average media sentiment score of 1.87 beat TELA Bio's score of 0.87 indicating that TELA Bio is being referred to more favorably in the media.
TELA Bio presently has a consensus target price of $13.00, suggesting a potential upside of 135.08%. CVRx has a consensus target price of $16.60, suggesting a potential upside of 138.85%. Given TELA Bio's higher probable upside, analysts plainly believe CVRx is more favorable than TELA Bio.
TELA Bio has a net margin of -63.82% compared to TELA Bio's net margin of -123.58%. TELA Bio's return on equity of -66.05% beat CVRx's return on equity.
TELA Bio has a beta of 1, suggesting that its stock price has a similar volatility profile to the S&P 500.Comparatively, CVRx has a beta of 1.35, suggesting that its stock price is 35% more volatile than the S&P 500.
CVRx has lower revenue, but higher earnings than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.
TELA Bio received 36 more outperform votes than CVRx when rated by MarketBeat users. Likewise, 72.22% of users gave TELA Bio an outperform vote while only 57.14% of users gave CVRx an outperform vote.
Summary
CVRx beats TELA Bio on 10 of the 18 factors compared between the two stocks.
Get CVRx News Delivered to You Automatically
Sign up to receive the latest news and ratings for CVRX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CVRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
